A Philadelphia magazine article in the "Best of Philly" issue profiles the Penn Medicine research team behind the breakthrough treatment that uses engineered versions of patients' own immune cells to fight their cancers, including Carl June, MD , David Porter, MD , Bruce Levine, PhD, and Michael Kalos, PhD, along with detailing the stories of several patients who are in remission following years of failed conventional therapies. "Science," the magazine writes, "is incremental. It's a slow and global grind, a steady accumulation of facts wrested from failure. But every once in a while, there really is a leap, and a small group of people can change how thousands think about the possibilities."
Read the full Philadelphia magazine article